Immuneering (IMRX) Gains (Losses) on Sale of Assets & Investments (2021 - 2026)
Immuneering (IMRX) posted Gains (Losses) on Sale of Assets & Investments of $112,353 for Q4 2022, compared with -$44,258 a year earlier and up 187.4% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Gains (Losses) on Sale of Assets & Investments (2021 - 2026) Analysis & Trends
For FY2022, Immuneering's Gains (Losses) on Sale of Assets & Investments came in at $18,889.
- In prior years, Immuneering's Gains (Losses) on Sale of Assets & Investments was -$49,009 in FY2021.
- According to Business Quant data, Gains (Losses) on Sale of Assets & Investments for the three prior quarters was $39,088 (Q3 2022), -$14,166 (Q2 2022) and -$118,386 (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Immuneering | 249.34 Mn | -375.49 Mn | - | -142,913.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -142,913.00 |
| Jun 30, 2026 | -165,235.00 |
| Mar 31, 2026 | -322,337.00 |
| Dec 31, 2025 | 81,332.00 |
| Dec 31, 2024 | -7,846.00 |
| Sep 30, 2024 | 7,845.00 |
| Jun 30, 2024 | 1,084.00 |
| Mar 31, 2024 | -306.00 |
| Dec 31, 2023 | -6,385.00 |
| Sep 30, 2023 | 7,825.00 |
| Jun 30, 2023 | -2,724.00 |
| Mar 31, 2023 | 30,626.00 |
| Dec 31, 2022 | 112,353.00 |
| Sep 30, 2022 | 39,088.00 |
| Jun 30, 2022 | -14,166.00 |
| Mar 31, 2022 | -118,386.00 |
| Dec 31, 2021 | -44,258.00 |
| Sep 30, 2021 | -4,751.00 |
API Access
Immuneering Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();